IRE favicon


Resource ID: #20435
Subject: Medicine
Source: Wall Street Journal (New York)
Date: 20-Jul-95


This article talks about a possible association between Baxter's intravenous drug called Gammagard and hepatitis. Baxter has pulled the drug off the market. The article says that as many as 350 people worldwide might have contracted the virus from the drug (which is used as a treatment for immune deficiency).

This file is not available for digital download. IRE members may place an order by emailing

141 Neff Annex   |   Missouri School of Journalism Columbia, MO 65211   |   573-882-2042   |   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram